Get started
Author

Min Wang

Observed name: M Wang
ORCID: 0009-0004-9364-1284
Observed ORCID: 0009-0004-9364-1284
OpenAlex ID: A5064147672
Novel mutations in the estrogen receptor messenger RNA in human breast cancers
1996 · L C Murphy, M Wang, et al. · The Journal of Clinical Endocrinology & Metabolism · 41
PRMT5 Inhibitors Regulate DNA Damage Repair Pathways in Cancer Cells and Improve Response to PARP Inhibition and Chemotherapies
2023 · Jack Carter, Michael Hulse, et al. · Cancer Research Communications · 35
PDF
FBXL5 attenuates RhoGDI2-induced cisplatin resistance in gastric cancer cells.
2016 · W-D Wu, M Wang, et al. · PubMed · 24
PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4 -Mutated Cancers
2025 · Michael Hulse, Min Wang, et al. · Cancer Research · 22
Metabolomic insights into the neuroprotective actions of Ziziphi spinosae semen and jujuboside B against Aβ-induced toxicity
2026 · Jinrui Liu, Yanqing Zhang, et al. · Journal of Ethnopharmacology · 7
Abstract 1646: Elucidating the molecular mechanism of action of the first in human SMARCA2 selective degrader PRT3789
2025 · Min Wang, Miles Cowart, et al. · Cancer Research · 2
Figure S10 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Figure S6 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Figure S2 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Table S4 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Table S6 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Figure S1 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Figure S4 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Figure S11 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Figure S5 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Table S5 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Table S7 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Figure S3 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Table S1 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Figure S8 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Data from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Table S2 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Figure S9 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Table S3 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Figure S7 from PRT3789 Is a First-in-Human SMARCA2-Selective Degrader That Induces Synthetic Lethality in SMARCA4-Mutated Cancers
2026 · Michael Hulse, Min Wang, et al.
Works count: 47
Citation count: 130
H-index: 5
I10-index: 4
Year
Topic
Type